Porcine Vaccine Market 2028 By Technology, Disease Indication, End User | The Insight Partners

report image

Porcine Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines); Disease Indication (Diarrhea, Swine Influenza, Arthritis, Bordatella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Others); End User (Veterinary Hospitals, Hog/Pig Production Farm)

Report Code: TIPRE00021695 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Infection of swine with porcine parvovirus (PPV) is reported across the world, which may be resulted into reproductive failure in swine or cutaneous lesions in piglets. The first vaccine to aid in the prevention of the porcine reproductive and respiratory syndrome (PRRS) was approved for use in Spain in 1994, since then a number of additional vaccines (comprising either attenuated or inactivated PRRSV) have been developed in the U.S. and Europe. These vaccines include a different strain of the virus of either the North American or European genotype. According to an article published in NCBI, in 2020, around 70% of pig producers are small farmers with farms fewer than 50 pigs each, and hygienic measures and feed of the pigs is not controlled, which has raised demand for porcine vaccines market.


Porcine vaccine market is driving due to factors such as increasing incidences of zoonotic diseases, increasing number of biotechnology companies, research institutes engaged in research and development of porcine vaccines, and government initiatives for funding agriculture and animal husbandry sector. However, the high cost of maintaining, handling, and storage of vaccines is likely to create a negative impact on the growth of this market.


The Porcine vaccine market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Porcine vaccine Market with detailed market segmentation by technology, disease indication and end user. The Porcine vaccine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Porcine vaccine market and offers key trends and opportunities in the market.


The Porcine vaccine market is segmented based on technology, disease indication and end user. Based on technology, market is segmented as inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, DNA vaccines. Based on disease indication, market is segmented as diarrhea, swine influenza, arthritis, Bordetella rhinitis, porcine reproductive and respiratory virus (PRRSV), porcine circovirus associated disease (PCVAD), others. Based on end user, market is segmented as veterinary hospitals, hog/pig production farm.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Porcine vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Porcine vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Porcine vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Porcine vaccine market in these regions.

Get more information on this report :


The report covers key developments in the Porcine vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Application and End user launches, Application and End user approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Porcine vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Porcine vaccine in the global market. Below mentioned is the list of few companies engaged in the Porcine vaccine Market.

The report also includes the profiles of key players in Porcine vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Bayer AG
  •   Bimeda Animal Health
  •   Boehringer Ingelheim GmbH
  •   Ceva Sante Animale
  •   Eli Lilly and Company
  •   Merck and Co., Inc.
  •   Sanofi S.A
  •   Vetoquinol
  •   Zoetis, Inc.
  •   Hipra
  •   Elanco
  •   Formosa Biomedical Inc.
  •   Shoken Pharmaceutical Co., Ltd
  •   MSD Animal Health

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Bayer AG
2. Bimeda Animal Health
3. Boehringer Ingelheim GmbH
4. Ceva Sante Animale
5. Eli Lilly and Company
6. Merck and Co., Inc.
7. Sanofi S.A
8. Vetoquinol
9. Zoetis, Inc.
10. Hipra
11. Elanco
12. Formosa Biomedical Inc.
13. Shoken Pharmaceutical Co., Ltd
14. MSD Animal Health
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount